Rajni Kannan Discusses Immune Related Adverse Events
Rajni Kannan, BS, MS, RN, ANP-BC, Perlmutter Cancer Center at NYU Langone, gives an overview of immune related adverse events (IRAEs).
Rajni Kannan, BS, MS, RN, ANP-BC, Perlmutter Cancer Center at NYU Langone, gives an overview of immune related adverse events (IRAEs).
Kannan says the adverse events seen in patients taking immunotherapy agents are classified differently than other adverse events. These new immunotherapy agents are activating T cells that not only go after the cancer, but also to work on the healthy tissues.
The most common side effects seen with immunotherapies are diarrhea and rash but patients may also experience pseudo hepatitis, endocrinopathies, and eye toxicities.
Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers
September 1st 2022In this episode of "The Vitals," Sarah Donahue, MPH, NP, AOCNP; Jamie Carroll, APRN, CNP, MSN; Theresa Wicklin Gillespie, PhD, MA, RN, FAAN; and Elizabeth Prechtel-Dunphy, DNP, RN, ANP-BC, AOCN, exchange clinical pearls for treating patients receiving antibody-drug conjugates.
